EFMH
BNTX icon

E Fund Management (HK)’s BioNTech BNTX Stock Holding History

E Fund Management (HK)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Buy
192
+50
+35% +$4.71K 0.01% 336
2026
Q1 		$12.6K Buy
+142
New +$14.6K 0.01% 307

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

E Fund Management (HK)'s BNTX Position: Q2 2026 in Review

E Fund Management (HK) increased its BioNTech (BNTX) stake by 35% in Q2 2026, buying an estimated $4.71K and bringing the position to 192 shares worth $17.9K. The position accounts for 0.01% of the portfolio, ranked #336.

E Fund Management (HK) first reported a position in BNTX in Q1 2026 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • E Fund Management (HK) held 192 shares of BioNTech worth $17.9K as of Q2 2026.
  • E Fund Management (HK) bought 50 BioNTech shares in Q2 2026, an estimated $4.71K.
  • BioNTech made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #336 holding.
  • E Fund Management (HK) first reported a position in BioNTech in Q1 2026 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.